[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365986-105":59,"doc-detail-365986-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","surface-keratin-1-a-tumor-selective-peptide-target-in-human-triple-negative-breast-cancer","Surface keratin 1, a tumor-selective peptide target in human triple-negative breast cancer","","Surface keratin 1 (K1) is identified as a cell-surface target in human triple-negative breast cancer (TNBC), where selective uptake is limited by the lack of a well-defined receptor. Immunohistochemical analysis shows significantly higher K1 in TNBC patient tissues than in normal breast tissues, with grade 3 tumors exhibiting higher (threefold) expression than grade 2. Mass spectrometry, peptide mass fingerprinting, and Western blot confirm elevated 67 kDa K1 in TNBC cell lysates. Intact TNBC cells display uniformly surface-associated K1, unlike normal mammary epithelial cells. A TNBC-selective peptide, 18–4, mediates K1-dependent endocytosis without disrupting endogenous cytoplasmic K1 assembly. These findings support cell-surface K1 as a promising directed delivery target using ligands such as peptide 18–4.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/surface-keratin-1-a-tumor-selective-peptide-target-in-human-triple-negative-breast-cancer/365986/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/surface-keratin-1-a-tumor-selective-peptide-target-in-human-triple-negative-breast-cancer/365986.png","ImageObject",300,407,{"name":92,"@type":93},"Bintang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"How does the TNBC-selective peptide 18–4 contribute to K1 targeting?","Question",{"text":112,"@type":113},"Peptide 18–4 is used for uptake via K1-mediated endocytosis in TNBC cells. Its presence does not affect the assembly of endogenous cytoplasmic K1, supporting K1 as a directed delivery target.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},365986,1791091137,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":137,"preview_page_count":19,"preview_urls":138},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nSurface keratin 1, a tumor-selective peptide target in human triplenegative breast cancer  \nShih-Jing Yao1, Farideh Amirrad2, Elmira Ziaei1, Azam Saghaeidehkordi1, Moom R. Roosan3, Kiumars Shamloo1, Ajay Sharma1, Rachita K. Sumbria1,4,6, Surya M. Nauli1,6,  \nChristopher G. Bunick5 & Kamaljit Kaur1,6􀀍  \nTargeting drugs to cancer cells via overexpressed cell-surface receptors has emerged as an effective therapeutic strategy for several cancers. However, identifying cell-surface receptors that allow selective uptake of targeting ligands by cancer cells—while sparing normal cells—remains a challenge, especially for triple-negative breast cancer (TNBC), which lacks a well-defined receptor for targeted delivery. In this study, immunohistochemical (IHC) analysis revealed that human TNBC patient tissues have significantly higher levels of keratin 1 (K1) compared to normal breast tissues. Among TNBC tissues, grade 3 tumors showed significantly higher (threefold) K1 expression compared to grade 2 tumors. We analyzed human TNBC and normal mammary epithelial cells to detect K1 from cell lysates using three methods: mass spectrometry, peptide mass fingerprinting, and Western blot. TNBC cell lysates confirmed the presence and high expression levels of 67 kDa K1 . Importantly, intact cells showed that K1 is uniformly present on the surface ofTNBC cells, while no or minimal cell-surface K1 was found in normal mammary epithelial cells using immunofluorescence confocal microscopy. Further, we show that cell-surface K1 was utilized by TNBC-selective peptide 18–4 for its uptake via cell-surface receptor (K1)-mediated endocytosis inTNBC cells, and the presence of peptide 18–4 did not affect the assembly of endogenous cytoplasmic K1. Taken together, our results demonstrate that K1 is overexpressed in human TNBC, and cell-surface K1 represents a promising new target for directed delivery inTNBC using targeting ligands such as peptide 18–4.  \nKeywords TNBC, Keratin 1 expression, Cell-surface keratin 1, Targeted drug delivery, Tumor-selective peptide  \nAbbreviations  \nADC BL1 BL2 CSKCSK1  \nCSRDox  \nER + /PR + HER2  \nIHC IRSIFK  \nAntibody–drug conjugate Basal-like 1  \nBasal-like 2  \nCell-surface keratin  \nCell-surface keratin 1  \nCell-surface receptor Doxorubicin  \nEstrogen and progesterone receptor positive Human epidermal growth factor receptor 2  \nImmunohistochemical Immunoreactive score Intermediate filament Keratins  \n1Department of Biomedical and Pharmaceutical Sciences, School of Pharmacy, Harry and Diane Rinker Health Science Campus, Chapman University, Irvine, CA 92618-1908, USA. 2Department of Pharmaceutical Sciences, Marshall B. Ketchum University, Fullerton, CA 92831-1699, USA. 3Department of Pharmacy Practice, School of Pharmacy, Harry and Diane Rinker Health Science Campus, Chapman University, Irvine, CA 92618-1908, USA. 4Department of Neurology, University of California, Irvine, CA 92697, USA. 5Department of Dermatology and Program in Translational Biomedicine, Yale University, New Haven, CT 06520-8059, USA. 6Center for Targeted Drug Delivery (CTDD), School of Pharmacy, Chapman University, Irvine, CA 92618-1908, USA. 􀀍 email: [kkaur@chapman.edu](kkaur@chapman.edu)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nK1  \nLAR LC–MS/MS M  \nMALDI-TOF mAb  \nPDC PRCr.t. TNBC  \nKeratin 1  \nLuminal androgen receptor  \nLiquid chromatography-tandem mass spectrometry Mesenchymal  \nMatrix assisted laser desorption/ionization-time offlight Monoclonal antibody  \nPeptide-drug conjugate  \nPeptide-radionuclide conjugate  \nRoom temperature  \nTriple-negative breast cancer  \nTargeting cancer cells via their overexpressed cell-surface receptors (CSRs) for drug delivery has emerged as a promising therapeutic strategy for treatment of several cancers1–6. In this approach, drug conjugates are designed by linking a drug to a targeting ligand through a linker ","cbCaiq2mJ7KlkLQ1","https://ap.wps.com/l/cbCaiq2mJ7KlkLQ1","pdf",2855775,15,"English","# Targeted delivery background\n## Role of cell-surface receptors in drug conjugates\n# Evidence for K1 in TNBC\n## IHC comparison between TNBC and normal tissues\n## Grade-dependent K1 expression\n## Detection methods for K1 (MS, peptide mass fingerprinting, Western blot)\n## Surface localization of K1 on intact cells\n# Peptide-mediated uptake\n## 18–4 enables K1-mediated endocytosis\n## Effect on endogenous cytoplasmic K1 assembly\n# Conclusion and therapeutic implication","[{\"question\":\"How does the TNBC-selective peptide 18–4 contribute to K1 targeting?\",\"answer\":\"Peptide 18–4 is used for uptake via K1-mediated endocytosis in TNBC cells. Its presence does not affect the assembly of endogenous cytoplasmic K1, supporting K1 as a directed delivery target.\"}]","Surface keratin 1, a tumor-selective peptide target in human triple-negative breast cancer | PDF",1790163406,38,[139,143,147,151],{"page_no":8,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e60f181cf5864ce9044dd8b873412afc.webp",983,1291,{"page_no":14,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d432f96d407089a7016d39f97eb98f94.webp",982,1290,{"page_no":81,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4469fdcff95d73c6439037173df385f5.webp",981,1289,{"page_no":19,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f3842d43ec78c485a69d71bd1a8a8f1.webp",980,1287]